Literature DB >> 11602722

Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro.

N Bannert1, M Farzan, D S Friend, H Ochi, K S Price, J Sodroski, J A Boyce.   

Abstract

Mast cells are critical components of innate and adaptive immunity that differentiate in tissues in situ from circulating committed progenitor cells. We now demonstrate that human cord blood-derived mast cell progenitors are susceptible to infection with macrophagetropic (M-tropic) and dualtropic human immunodeficiency virus type 1 (HIV-1) isolates but not with T-cell-tropic (T-tropic) strains. Mast cell progenitors (c-kit(+) CD13(+) cells with chloroacetate esterase activity) were purified from 4-week-old cultures of cord blood mononuclear cells maintained in stem cell factor, interleukin-6 (IL-6), and IL-10 using a CD14 depletion column. These progenitors expressed CCR3, CCR5, and CXCR4, as well as low levels of CD4. When infected in vitro with viruses pseudotyped with different HIV and simian immunodeficiency virus envelope glycoproteins, only M-tropic and dualtropic, but not T-tropic, viruses were able to enter mast cell progenitors. Both the CCR5-specific monoclonal antibody 2D7 and TAK-779, a nonpeptide inhibitor of CCR5-mediated viral entry, blocked HIV-1 strain ADA infection by >80%. Cultures infected with replication-competent virus produced progressively increasing amounts of virus for 21 days as indicated by p24 antigen detection. Mast cell progenitors that were exposed to an M-tropic, green fluorescent protein-expressing HIV-1 strain exhibited fluorescence indicative of viral entry and replication on a single-cell level and retained virus production during differentiation. The trafficking of mast cell progenitors to multiple tissues, combined with the long life span of mature mast cells, suggests that they could provide a widespread and persistent HIV reservoir in AIDS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602722      PMCID: PMC114662          DOI: 10.1128/JVI.75.22.10808-10814.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

Review 2.  Mast cells in the brain: evidence and functional significance.

Authors:  R Silver; A J Silverman; L Vitković; I I Lederhendler
Journal:  Trends Neurosci       Date:  1996-01       Impact factor: 13.837

3.  Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).

Authors:  A S Kirshenbaum; J P Goff; T Semere; B Foster; L M Scott; D D Metcalfe
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

4.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

Review 5.  Human immunodeficiency virus and the skin: selected controversies.

Authors:  M Duvic
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

6.  Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.

Authors:  H Agis; M Willheim; W R Sperr; A Wilfing; E Krömer; E Kabrna; E Spanblöchl; H Strobl; K Geissler; A Spittler; G Boltz-Nitulescu; O Majdic; K Lechner; P Valent
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.

Authors:  A M Irani; S S Craig; G DeBlois; C O Elson; N M Schechter; L B Schwartz
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells.

Authors:  H Saito; M Ebisawa; H Tachimoto; M Shichijo; K Fukagawa; K Matsumoto; Y Iikura; T Awaji; G Tsujimoto; M Yanagida; H Uzumaki; G Takahashi; K Tsuji; T Nakahata
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

9.  Distribution of SIV infection in the gastrointestinal tract of rhesus macaques at early and terminal stages of AIDS.

Authors:  C Heise; P Vogel; C J Miller; A Lackner; S Dandekar
Journal:  J Med Primatol       Date:  1993 Feb-May       Impact factor: 0.667

10.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.

Authors:  R Malaviya; T Ikeda; E Ross; S N Abraham
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

View more
  18 in total

1.  Short communication: Colony-forming hematopoietic progenitor cells are not preferentially infected by HIV type 1 subtypes A and D in vivo.

Authors:  Caroline E Mullis; Amy E Oliver; Leigh Anne Eller; David Guwatudde; Amy C Mueller; Michael A Eller; Hannah Kibuuka; Merlin Robb; Thomas C Quinn; Andrew D Redd
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

Review 2.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 3.  Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms.

Authors:  Hae Woong Choi; Soman N Abraham
Journal:  Mol Immunol       Date:  2014-03-11       Impact factor: 4.407

Review 4.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 5.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

6.  Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.

Authors:  Mark S Sundrud; Scott E Vancompernolle; Karla A Eger; Tullia C Bruno; Arun Subramaniam; Srinivas Mummidi; Sunil K Ahuja; Derya Unutmaz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

7.  Human Mucosal Mast Cells Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells.

Authors:  Ai-Ping Jiang; Jin-Feng Jiang; Ji-Fu Wei; Ming-Gao Guo; Yan Qin; Qian-Qian Guo; Li Ma; Bao-Chi Liu; Xiaolei Wang; Ronald S Veazey; Yong-Bing Ding; Jian-Hua Wang
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

8.  Ancient origin of mast cells.

Authors:  G William Wong; Lisheng Zhuo; Koji Kimata; Bing K Lam; Nori Satoh; Richard L Stevens
Journal:  Biochem Biophys Res Commun       Date:  2014-08-02       Impact factor: 3.575

Review 9.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

10.  Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.

Authors:  Ann Marie Nelson; Aaron Auerbach; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2009-09-22       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.